Amryt Pharma

Share on: 
Website: Amryt Pharma
Business Area(s): 
Description: 

Developing treatments for Epidermolysis Bullosa, a group of rare and genetic disorders of the skin, characterized by skin fragility which can be severe and cause recurrent blistering of the skin in response to minor trauma or friction; Homozygous Familial Hypercholesterolaemia, a rare and severe genetic disease, causing excessive levels of low-density lipoprotein cholesterol (LDL-C); and Lipodystrophy, a condition caused by uncontrolled loss of fat tissue that is not due to dieting.

Career Page(s): 
Location(s): 
London
United Kingdom
Dublin
Ireland
Boston MA
United States
Manufacturing
Niefern-Oschelbronn
Germany